EMEA-002744-PIP01-19 - paediatric investigation plan

Atropine sulfate
PIPHuman

Key facts

Active Substance
Atropine sulfate
Therapeutic area
Ophthalmology
Decision number
P/0229/2021
PIP number
EMEA-002744-PIP01-19
Pharmaceutical form(s)
Eye drops, solution
Condition(s) / indication(s)
Treatment of myopia
Route(s) of administration
Topical use
Contact for public enquiries

Nevakar Inc.

E-mail: info@nevakar.com
Tel: +1 9083677400

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
Decision date

Decision

Share this page